Roche AI Platform Gets CE Mark to Combat Kidney Disease
BASEL, Switzerland, Oct. 6, 2025 — Roche announced that it has received CE-mark approval for the AI-based Kidney Klinrisk...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BASEL, Switzerland, Oct. 6, 2025 — Roche announced that it has received CE-mark approval for the AI-based Kidney Klinrisk...
CHELMSFORD, Mass., Sept. 30, 2025 — The U.S. Food and Drug Administration (FDA) has approved the ZOLL Zenix Monitor/Defibrillator,...
ANN ARBOR, Mich., September 23, 2025 – Micromedex has launched an AI-powered search capability to provide clinicians with faster,...
CANTON, Conn., September 18, 2025 – Kelyniam Global, Inc., a leader in custom cranial and craniofacial implant solutions, announced...
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
September 17, 2025 — The Hague, The Netherlands Amber Implants has received FDA 510(k) clearance for its VCFix® Spinal...
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Fort Lauderdale, FL – September 4, 2025 – The first U.S. clinical cases using the CERTA™ Access System, a...
